363 related articles for article (PubMed ID: 18997107)
1. Structural and functional analyses of liver cysts from the BALB/c-cpk mouse model of polycystic kidney disease.
Muchatuta MN; Gattone VH; Witzmann FA; Blazer-Yost BL
Exp Biol Med (Maywood); 2009 Jan; 234(1):17-27. PubMed ID: 18997107
[TBL] [Abstract][Full Text] [Related]
2. Murine autosomal recessive polycystic kidney disease with multiorgan involvement induced by the cpk gene.
Gattone VH; MacNaughton KA; Kraybill AL
Anat Rec; 1996 Jul; 245(3):488-99. PubMed ID: 8800407
[TBL] [Abstract][Full Text] [Related]
3. Protein composition of liver cyst fluid from the BALB/c-cpk/+ mouse model of autosomal recessive polycystic kidney disease.
Lai X; Blazer-Yost BL; Gattone VH; Muchatuta MN; Witzmann FA
Proteomics; 2009 Jul; 9(14):3775-82. PubMed ID: 19639592
[TBL] [Abstract][Full Text] [Related]
4. Proliferation-Independent Initiation of Biliary Cysts in Polycystic Liver Diseases.
Beaudry JB; Cordi S; Demarez C; Lepreux S; Pierreux CE; Lemaigre FP
PLoS One; 2015; 10(6):e0132295. PubMed ID: 26125584
[TBL] [Abstract][Full Text] [Related]
5. The microanatomy of the intrahepatic bile duct in polycystic disease: comparison of the cpk mouse and human.
Grimm PC; Crocker JF; Malatjalian DA; Ogborn MR
J Exp Pathol (Oxford); 1990 Feb; 71(1):119-31. PubMed ID: 2310613
[TBL] [Abstract][Full Text] [Related]
6. The pck rat: a new model that resembles human autosomal dominant polycystic kidney and liver disease.
Lager DJ; Qian Q; Bengal RJ; Ishibashi M; Torres VE
Kidney Int; 2001 Jan; 59(1):126-36. PubMed ID: 11135065
[TBL] [Abstract][Full Text] [Related]
7. Hepato-renal pathology in pkd2ws25/- mice, an animal model of autosomal dominant polycystic kidney disease.
Stroope A; Radtke B; Huang B; Masyuk T; Torres V; Ritman E; LaRusso N
Am J Pathol; 2010 Mar; 176(3):1282-91. PubMed ID: 20093497
[TBL] [Abstract][Full Text] [Related]
8. Polycystic kidney and liver disease and corticosterone changes in the cpk mouse.
Crocker JF; Blecher SR; Givner ML; McCarthy SC
Kidney Int; 1987 May; 31(5):1088-91. PubMed ID: 3599649
[TBL] [Abstract][Full Text] [Related]
9. Development of autosomal recessive polycystic kidney disease in BALB/c-cpk/cpk mice.
Ricker JL; Gattone VH; Calvet JP; Rankin CA
J Am Soc Nephrol; 2000 Oct; 11(10):1837-1847. PubMed ID: 11004214
[TBL] [Abstract][Full Text] [Related]
10. Galectin-3 associates with the primary cilium and modulates cyst growth in congenital polycystic kidney disease.
Chiu MG; Johnson TM; Woolf AS; Dahm-Vicker EM; Long DA; Guay-Woodford L; Hillman KA; Bawumia S; Venner K; Hughes RC; Poirier F; Winyard PJ
Am J Pathol; 2006 Dec; 169(6):1925-38. PubMed ID: 17148658
[TBL] [Abstract][Full Text] [Related]
11. Hepatic cystogenesis is associated with abnormal expression and location of ion transporters and water channels in an animal model of autosomal recessive polycystic kidney disease.
Banales JM; Masyuk TV; Bogert PS; Huang BQ; Gradilone SA; Lee SO; Stroope AJ; Masyuk AI; Medina JF; LaRusso NF
Am J Pathol; 2008 Dec; 173(6):1637-46. PubMed ID: 18988797
[TBL] [Abstract][Full Text] [Related]
12. The liver in autosomal dominant polycystic kidney disease. Implications for pathogenesis.
Ramos A; Torres VE; Holley KE; Offord KP; Rakela J; Ludwig J
Arch Pathol Lab Med; 1990 Feb; 114(2):180-4. PubMed ID: 2302034
[TBL] [Abstract][Full Text] [Related]
13. Octreotide inhibits hepatic cystogenesis in a rodent model of polycystic liver disease by reducing cholangiocyte adenosine 3',5'-cyclic monophosphate.
Masyuk TV; Masyuk AI; Torres VE; Harris PC; Larusso NF
Gastroenterology; 2007 Mar; 132(3):1104-16. PubMed ID: 17383431
[TBL] [Abstract][Full Text] [Related]
14. Somatic second-hit mutations leads to polycystic liver diseases.
Banales JM; Munoz-Garrido P; Bujanda L
World J Gastroenterol; 2013 Jan; 19(1):141-3. PubMed ID: 23326178
[TBL] [Abstract][Full Text] [Related]
15. Multiorgan mRNA misexpression in murine autosomal recessive polycystic kidney disease.
Gattone VH; Ricker JL; Trambaugh CM; Klein RM
Kidney Int; 2002 Nov; 62(5):1560-9. PubMed ID: 12371956
[TBL] [Abstract][Full Text] [Related]
16. Apico-basal polarity in polycystic kidney disease epithelia.
Wilson PD
Biochim Biophys Acta; 2011 Oct; 1812(10):1239-48. PubMed ID: 21658447
[TBL] [Abstract][Full Text] [Related]
17. Cystin, a novel cilia-associated protein, is disrupted in the cpk mouse model of polycystic kidney disease.
Hou X; Mrug M; Yoder BK; Lefkowitz EJ; Kremmidiotis G; D'Eustachio P; Beier DR; Guay-Woodford LM
J Clin Invest; 2002 Feb; 109(4):533-40. PubMed ID: 11854326
[TBL] [Abstract][Full Text] [Related]
18. Acceleration of polycystic kidney disease progression in cpk mice carrying a deletion in the homeodomain protein Cux1.
Alcalay NI; Sharma M; Vassmer D; Chapman B; Paul B; Zhou J; Brantley JG; Wallace DP; Maser RL; Vanden Heuvel GB
Am J Physiol Renal Physiol; 2008 Dec; 295(6):F1725-34. PubMed ID: 18829740
[TBL] [Abstract][Full Text] [Related]
19. Pax2 gene dosage influences cystogenesis in autosomal dominant polycystic kidney disease.
Stayner C; Iglesias DM; Goodyer PR; Ellis L; Germino G; Zhou J; Eccles MR
Hum Mol Genet; 2006 Dec; 15(24):3520-8. PubMed ID: 17082250
[TBL] [Abstract][Full Text] [Related]
20. Abnormal expression of MUC1 apomucin and mature MUC1 mucin in biliary epithelial cells in various cystic liver diseases.
Sasaki M; Nakanuma Y
Hepatology; 1996 Sep; 24(3):539-43. PubMed ID: 8781320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
